Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma and Extrahepatic Metastasis
Journal of Liver Cancer
;
: 82-85, 2016.
Artigo
em Coreano
| WPRIM
| ID: wpr-76016
ABSTRACT
Transarterial chemoembolization (TACE) has been widely performed as a treatment for unresectable hepatocellular carcinoma (HCC). Recently extrahepatic metastasis (EHM) of HCC is increasing due to improvement of survival. Sorafenib has been generally accepted as a standard treatment in advanced HCC. However, many HCC patients with EHM are treated with TACE in real-world clinical practice because sorafenib has modest efficacy and the main cause of death in the patients with EHM is hepatic failure. In this review, the usefulness of TACE for the patients with HCC and EHM will be discussed.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Causas de Morte
/
Falência Hepática
/
Carcinoma Hepatocelular
/
Metástase Neoplásica
Limite:
Humanos
Idioma:
Coreano
Revista:
Journal of Liver Cancer
Ano de publicação:
2016
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS